Search

everythinglearnresearchcommunity

for

Search:↓

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Mutations in certain receptors can cause diseases and offer new treatment options.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

About 20% of Japanese macaques had head alopecia, and stress and environment might cause hair loss.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Non-surgical treatments like thread lifts, PRP therapy, HIFU, and radiofrequency effectively rejuvenate and tighten facial skin.

Using urinary bladder matrix and platelet rich plasma can effectively treat transplant scars and prevent hair loss.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

The article concludes that a thorough diagnosis and treatment plan, including medications, non-invasive methods, or surgery, is important for managing hair loss, with a combination of minoxidil and finasteride being particularly effective.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

OCT can effectively screen and diagnose various medical conditions non-invasively.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Stopping fluoride toothpaste use might improve perioral dermatitis.

The document summarizes recent dermatological treatments and advances in areas like pediatric care, wound healing, skin closure, light-based therapies, pigment disorders, hair loss, immunotherapy, infection management, melanoma, drug reactions, and facial rejuvenation.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Trichoscopy is a useful method for identifying primary cicatricial alopecias and their specific types.

Immune cells affect hair growth and could lead to new hair loss treatments.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.